Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ (CTTNKTL-Ⅲ/Ⅳ)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Zhengzhou University
Second Hospital of Shanxi Medical University
Shanxi Province Cancer Hospital
Wuhan University
Wuhan TongJi Hospital
Wuhan Union Hospital, China
Qingdao University
Cancer Hospital of Guizhou Province
Xinyang Central Hospital
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Information provided by (Responsible Party):
Mingzhi Zhang, Zhengzhou University Identifier:
First received: November 29, 2011
Last updated: July 15, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2019
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)